Physician profile
Thang Le
NPI 1013277821
$4,869.76
in general payments reported to CMS, 2019-2025
10 companies · $20.47 in 2025
The $20.47 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,407 · 2020: $312 · 2021: $1,801 · 2022: $857 · 2023: $105 · 2024: $367 · 2025: $20.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,270.92 | 2019 | |
| Penumbra, INC. | $1,196.65 | 2019-2022 | |
| Sirtex Medical INC | $695.10 | 2021-2025 | Sir-Spheres Microspheres |
| Inari Medical, INC. | $686.29 | 2021 | |
| Medtronic, INC. | $585.24 | 2022 | |
| Medical Device Business Services, INC. | $124.19 | 2019 | |
| Bard Peripheral Vascular, INC. | $101.61 | 2020-2024 | Pristine, Rotarexs 6 F X 135 Cm |
| Cardiovascular Systems INC. | $96.93 | 2021 | |
| Stryker Corporation | $57.08 | 2024 | Trevo, Axs Vecta 71 |
| Angiodynamics, INC. | $55.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thang Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.